Stockreport

United Therapeutics Corporation Announces Full Enrollment of the TETON 1 Study of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary Fibrosis

United Therapeutics Corporation  (UTHR) 
Last united therapeutics corporation earnings: 4/29 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.unither.com/investor-relations
PDF Over 100,000 patients in the United States have IPF, with only two approved therapies available that only slow the course of disease progressionTop line data expected in [Read more]